Docs Who Lift

Latest Episodes:

Joy Prescriptions May 13, 2025

Show notes

Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions. Learn how to stop chasing perfection and embrace connection.

00:00Introduction to Dr. Tiffany Moon

02:02Journey to Reality TV: The Real Housewives of Dallas

05:58Life After Reality TV: Finding Joy and Purpose

09:59The Joy Prescription: A New Approach to Life

17:01Work-Life Integration: Balancing Career and Family

22:09Empowering Women: The Lead Her Summit

22:33Tiffany's Journey: From Childhood to Medical Success

24:43The Quest for Joy: Breaking the Hedonic Treadmill

26:42Finding Gratitude and Connection in Life

28:37Coping Mechanisms: Humor and Self-Reflection

29:57The Joy Prescription: A Path for High Achievers

32:29Reconstructing Identity: Beyond External Validation

35:37The Impact of Sports on Identity and Achievement

40:54Closing Thoughts: Embracing Joy and Connection

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Zepbound versus Wegovy May 12, 2025

Show notes

Tirzepatide is more effective for weight loss than semaglutide.
Cost-effectiveness is crucial in prescribing weight loss medications.
Patients with severe obesity should receive more expensive medications for better outcomes.
Both medications show significant benefits for obesity-related conditions.
Long-term studies indicate sustained weight loss with both drugs.
Gender differences affect weight loss outcomes with these medications.
Safety profiles show tirzepatide may be better tolerated than semaglutide.
The need for affordable drug pricing is emphasized.
Clinical benefits extend beyond weight loss to include metabolic health.
Future studies are needed to confirm cardiovascular benefits of tirzepatide.

Click here to see the study

Click here to join Dr. Spencer's new online clinic

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH). May 02, 2025

Show notes

Takeaways

MASH is a significant obesity-related complication.
Semaglutide shows promise in treating MASH.
Weight loss is crucial for improving liver health.
Bariatric surgery remains the most effective treatment.
The Essence trial indicates a 63% resolution of NASH.
New medications are being developed for obesity treatment.
Early intervention is key to preventing severe liver damage.
Accessibility of medications is a major concern.
Comparative studies are essential for evaluating new treatments.
Future treatments may include innovative delivery methods.

Chapters

00:00 Introduction to MASH and Semaglutide Study

04:29 Understanding Metabolic Dysfunction and Its Implications

08:02 Essence Trial: Semaglutide's Impact on MASH

12:58 Comparative Analysis of New Treatments for MASH

17:30 The Future of Obesity Treatment and Drug Accessibility

Join Vineyard - Dr. Spencer's online clinic

See the study

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Top 5 Women's Fitness Myths Apr 25, 2025

Show notes

Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women.

Follow Dr. Lauren's instagram

Join Dr. Spencer's online clinic

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

GLP-1 and metabolism and depression Apr 11, 2025

Show notes

Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case of tirzepatide induced anhedonia.

Here is the tirzepatide study

If interested in joining Dr. Spencer's clinic Vineyard - Click Here

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Do GLP-1 meds cause more fat cells? Mar 19, 2025

Show notes

Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.

Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine.

Join Dr. Spencer's online clinic that specializes in GLP-1 medicines

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Future of medicine - Direct Care Mar 11, 2025

Show notes

Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine.

Learn about how bypassing insurance and creating a relationship directly with a doctor can improve your health and save money in the long run.

Follow Dr. Qiu on Linked in

See Dr. Spencer's direct care model with Vineyard

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tirzepatide and Muscle Loss with Dr. Grant Tinsley Feb 28, 2025

Show notes

Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is lost with tirzepatide, the most powerful medicine available for weight loss.

Learn:

The difference between fat free mass and lean mass and lean soft tissue and muscle.

If GLP-1 medicines cause muscle loss specifically

How to minimize muscle loss when taking these medicines

Our new study together.

Click here for the tirzepatide paper

Click here to see Dr. Grant Tinsely's Instagram

Click here to join Vineyard

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Super Bowl Hims and Hers Ad Feb 17, 2025

Show notes

Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.